| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A composition providing protection against dental caries comprising an antigenic protein fromStreptococcus mutans; use as a vaccine etc.; purification by chromatography
|
|
|
1986
|
4 |
1 |
p. 62-
1 p.
|
article
|
| 2 |
Adjuvant and antitumour activities of synthetic lipid A analogues
|
Ukei, Shigeki
|
|
1986
|
4 |
1 |
p. 21-24
4 p.
|
article
|
| 3 |
Adult T lymphocyte leukaemia virus antigen polypeptide encoded byenv gene and used for detecting adult T lymphocyte leukemia; vector preparation
|
|
|
1986
|
4 |
1 |
p. 64-
1 p.
|
article
|
| 4 |
Antibodies to a synthetic peptide from the preS 120–145 region of the hepatitis B virus envelope are virus-neutralizing
|
Neurath, A. Robert
|
|
1986
|
4 |
1 |
p. 35-37
3 p.
|
article
|
| 5 |
Antigenic material for vaccination against malaria comprises amino acid residues sequence of natural antigen and intraerythrocytic forms ofPlasmodium parasites
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 6 |
Anti-periodontitis antibody and vaccine utilizingStreptomyces viscosus orBacteroides gingivarius antigen
|
|
|
1986
|
4 |
1 |
p. 64-
1 p.
|
article
|
| 7 |
Biochemical and antigenic analysis using monoclonal antibodies of a series of influenza A (H3N2) and (H1N1) virus reassortants
|
Oxford, J.S.
|
|
1986
|
4 |
1 |
p. 9-14
6 p.
|
article
|
| 8 |
Cloned DNA encodingPlasmodium falciparu P.195 protein useful in malaria vaccine production
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 9 |
Combined vaccine containing inactivated Newcastle-disease virus and adeno-like virus for protection against Newcastle disease and egg production drop
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 10 |
Determination of potency of streptococcal preparations such as bacterins fromStreptococcus equi for antigen preparations used as vaccine
|
|
|
1986
|
4 |
1 |
p. 63-
1 p.
|
article
|
| 11 |
Direct isolation of hepatitis a virus from huma stools with direct passaging in African green monkey kidney cell for application to vaccine preparation
|
|
|
1986
|
4 |
1 |
p. 63-
1 p.
|
article
|
| 12 |
Editorial Board
|
|
|
1986
|
4 |
1 |
p. CO2-
1 p.
|
article
|
| 13 |
Effect of low level immunity on response to live rubella virus vaccine
|
Väänänen, Pertti
|
|
1986
|
4 |
1 |
p. 5-8
4 p.
|
article
|
| 14 |
ELISA detection of influenza haemagglutinin depends on its molecular environment
|
Sinyakov, M.S.
|
|
1986
|
4 |
1 |
p. 3-4
2 p.
|
article
|
| 15 |
Erratum
|
|
|
1986
|
4 |
1 |
p. 69-
1 p.
|
article
|
| 16 |
Feline calcivirus vaccine
|
|
|
1986
|
4 |
1 |
p. 62-
1 p.
|
article
|
| 17 |
Foot-rot vaccine for ruminants being an antigenic preparation which will bind with fimbrial antigens of causative agentBacteriodes nodosus
|
|
|
1986
|
4 |
1 |
p. 62-
1 p.
|
article
|
| 18 |
Guidelines for the development of recombinant vaccinia viruses for use as vaccines
|
|
|
1986
|
4 |
1 |
p. 67-69
3 p.
|
article
|
| 19 |
Herpes simplex virus type I subunit antigen extraction from infected fowl embryo cells for vaccine preparation
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 20 |
Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine
|
Dreesen, David W.
|
|
1986
|
4 |
1 |
p. 45-49
5 p.
|
article
|
| 21 |
Immunotherapeutic agent derived fromMycobacterium vaccae for vaccination against persistent microorganisms causing tuberculosis or leprosy
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 22 |
Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports
|
Strassburg, Marc A.
|
|
1986
|
4 |
1 |
p. 38-44
7 p.
|
article
|
| 23 |
Influenza virus strain B Leningrad 489-80 used to produce inactivated influenza vaccine
|
|
|
1986
|
4 |
1 |
p. 62-
1 p.
|
article
|
| 24 |
Intramuscular and intravaginal vaccination of pregnant cows with thymidine kinase-negative, temperature-resistant infectious bovine rhinotracheitis virus (bovine herpes virus 1)
|
Kit, Saul
|
|
1986
|
4 |
1 |
p. 55-61
7 p.
|
article
|
| 25 |
In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children
|
Edwards, Kathryn M.
|
|
1986
|
4 |
1 |
p. 50-54
5 p.
|
article
|
| 26 |
Large-scale production of poliomyelitis vaccine with separate cultivation of virus in a medium on microcarriers; Vero cell culture
|
|
|
1986
|
4 |
1 |
p. 63-
1 p.
|
article
|
| 27 |
Moraxella bovis vaccine containingMoraxella bovis protease or bacterin containing proteolytic component
|
|
|
1986
|
4 |
1 |
p. 62-
1 p.
|
article
|
| 28 |
New adult T-lymphocyte leukaemia virus antigen polypeptide useful in diagnosis and vaccine preparation; vector preparation andenv gene cloning
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 29 |
New DNA sequences encoding hepatitis A virus antigens useful for eliciting normal immune response and in vaccine for protection against the virus
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 30 |
New toxoid as inactivated form of toxin for use in vaccines is obtained from an organism transformed by a gene
|
|
|
1986
|
4 |
1 |
p. 62-
1 p.
|
article
|
| 31 |
Producing whooping cough vaccine with reduced side-effects by culturing and selecting strains ofBordetella infected with phages isolated fromBordetella pertussis
|
|
|
1986
|
4 |
1 |
p. 63-
1 p.
|
article
|
| 32 |
Production of antigens ofPlasmodium species especiallyPlasmodium falciparum by recombinant DNA methods giving polypeptides for protection against malaria or for diagnosis
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 33 |
Production of excreted transfer factor for specific antigen by collection and treatment of colostrum from lactating mammal, e.g. female cattle; use as vaccine
|
|
|
1986
|
4 |
1 |
p. 62-63
2 p.
|
article
|
| 34 |
Production of hepatitis B vaccine by treatment of hepatitis B virus surface antigen with plasmin
|
|
|
1986
|
4 |
1 |
p. 64-
1 p.
|
article
|
| 35 |
Production of live bacterial vaccines unable to form a chain of infection prepared from strains highly sensitive to surfactant
|
|
|
1986
|
4 |
1 |
p. 63-64
2 p.
|
article
|
| 36 |
Production of parasitic worm helminth antigen for use in vaccine or diagnosis involving genetic modification of an organism related to the worm to give a mutant and cultivation of this mutant
|
|
|
1986
|
4 |
1 |
p. 64-
1 p.
|
article
|
| 37 |
Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotaviruses
|
Clark, H. Fred
|
|
1986
|
4 |
1 |
p. 25-31
7 p.
|
article
|
| 38 |
Safety and immunogenicity of a polyvalentKlebsiella capsular polysaccharide vaccine in humans
|
Cryz Jr., S.J.
|
|
1986
|
4 |
1 |
p. 15-20
6 p.
|
article
|
| 39 |
The devil and the deep blue sea
|
|
|
1986
|
4 |
1 |
p. 2-
1 p.
|
article
|
| 40 |
The future of immunostimulants A Franco-Japanese symposium
|
|
|
1986
|
4 |
1 |
p. 66-67
2 p.
|
article
|
| 41 |
Trial of inactivated Japanese encephalitis vaccine in children with underlying diseases
|
Yamada, Akira
|
|
1986
|
4 |
1 |
p. 32-34
3 p.
|
article
|
| 42 |
Vaccination againstBordetella bronchiseptica infections preparations and administration of intra-respiratory vaccine
|
|
|
1986
|
4 |
1 |
p. 64-65
2 p.
|
article
|
| 43 |
Vaccine against acute diarrhoea caused by human rotavirus comprises live attenuated strain of two specific deposited strains of Australian rotavirus
|
|
|
1986
|
4 |
1 |
p. 65-
1 p.
|
article
|
| 44 |
Vaccine against infections bursal disease in fowl comprises live or inactivated virus ATCC VR-2041
|
|
|
1986
|
4 |
1 |
p. 64-
1 p.
|
article
|
| 45 |
Vaccines containing attenuated pathogen, e.g.Straphylococcus aureus grown in cold-blooded animal protein
|
|
|
1986
|
4 |
1 |
p. 63-
1 p.
|
article
|
Journal description